Association of decreased external pulmonary function with cognitive impairments


如何引用文章

全文:

详细

Aim. To examine the association between the basic indicators of external respiratory function (ERF) and cognitive impairments (CIs). Subjects and methods. The materials of a population-based cross-sectional study were used in the investigation; a representative sample consisted of 3818 men and women aged 45-69 years. Forced expiratory volume in the first second (FEV1), the ratio of FEV1 to forced vital capacity (FVC) were determined to assess ERF. CIs were evaluated using the 10-word test described by A.R. Luria, Cog-sum indices (the sum of correctly reproduced words with 3 attempts), and Cog-mean=Cog-sum/3. Results. In patients with an FEV1/FVC <70%, the probability of a Cog-sum of <20 scores was twice higher than in those with an FEV1/FVC ≥70%; in patients with an FEV1 <80%, the probability of a Cog-sum of <20 scores was also 2 times higher than in those with an FEV1 ≥80%. Multiple regression analysis revealed no significant associations between Cog-sum index and smoking index, body mass index, and blood pressure. Cog-sum was inversely related to age and directly related to FEV1 and female sex. Binary logistic regression analysis showed that gender, age, and FEV1 were statistically significant variables. The relative risk of a Cog-sum of <20 that was 1.7 times higher in the men than in the women, 1.8 times higher in the patients with an FEV1 <80% than in those with an FEV1 ≥80% (model 1), 1.7 times higher in the patients with an FEV1/FVC <70% than in those with FEV1/FVC ≥70% (model 2) increased with age. Conclusion. The decrease in the basic indicators of ERF (FEV1, FEV1/FVC) is an independent predictor of CIs.

参考

  1. Larrabee GJ, Crook TM. Estimated prevalence of age associated memory impairment derived from standardized tests of memory function. Int Psychogeriatr. 1994;6(1):95-104. doi: 10.1017/s1041610294001663.
  2. Ahmadzadeh GH, Farhat A, Soltani D. Prevalence of cognitive dysfunction in old patients admitted in emergency room. Neurodegenerative Dis. 2007;4(1):124.
  3. Dodd JW. Lung disease as a determinant of cognitive decline and dementia. Alzheimers Res Ther. 2015;7(1):32. doi: 10.1186/s13195-015-0116-3.
  4. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: GOLD Executive Summary Updated 2003. Am J Respir Crit Care Med. 2001;163: 1256-1276. doi: 10.1081/copd-120030163.
  5. Hankinson JL, Odencrantz JR, Fedan Hankinson KB. Spirometric Reference Values from a Sample of the General U.S. Population. Am J Respir Crit Care Med. 1999;159:179-187. doi: 10.1164/ajrccm.159.1.9712108.
  6. Локшина А.Б., Захаров В.В. Когнитивные нарушения в общеклинической практике. Врач. 2009;4:21-25.
  7. Чучалин А.Г., Черняк А.В., Чикина С.Ю. Функциональная диагностика в пульмонологии. Практическое руководство. М.: Атмосфера; 2009.
  8. Шмелев Е.И. Бронхообструктивный синдром — универсальное патологическое состояние в пульмонологии. Пульмонология и аллергология. 2006;1:3-8.
  9. Stephan BC, Brayne C, Savva GM, Matthews FE. Medical Research Council Cognitive Function and Ageing Study, Оccurrence of medical co-morbidity in mild cognitive impairment: implications for generalisation of MCI research. Age Ageing. 2011;40:501-507. doi: 10.1093/ageing/afr057.
  10. Dodd JW, Getov SV, Jones PW. Cognitive function in COPD. Eur Respir J. 2010;35:913-922. doi: 10.1183/09031936.00125109.
  11. Одинак М.М., Литвиненко И.В., Колчева Ю.А. Когнитивные нарушения и церебральная гемодинамика при хронической обструктивной болезни легких и др. Вестник Российской военно-медицинской академии. 2011;35(3):8-13.
  12. Li J, Fei GH. The unique alterations of hippocampus and cognitive impairment in chronic obstructive pulmonary disease. Respir Res. 2013;14:140. doi: 10.1186/1465-9921-14-140.
  13. Zhang H, Wang X, Lin J, Sun Y, Huang Y, Yang T. Reduced regional gray matter volume in patients with chronic obstructive pulmonary disease: a voxel-based morphometry study. Am J Neuroradiol. 2013;34:334-339. doi: 10.3174/ajnr.a3235.
  14. Bozek A, Krajewska J, Jarzab J. The improvement of cognitive functions in patients with bronchial asthma after therapy. J Asthma. 2010;47:1148-1152. doi: 10.3109/02770903.2010.513077.
  15. Caldera-Alvarado G, Khan DA, Defina LF, Pieper A, Brown ES. Relationship between asthma and cognition: the Cooper Center Longitudinal Study. Allergy. 2013;68:545-548. doi: 10.1111/all.12125.
  16. Rusanen M, Ngandu T, Laatikainen T, Tuomilehto J, Soininen H, Kivipelto M. Chronic obstructive pulmonary disease and asthma and the risk of mild cognitive impairment and dementia: a population based CAIDE study. Curr Alzheimer Res. 2013;10:549-555. doi: 10.2174/1567205011310050011.
  17. Chen MH, Li CT, Tsai CF, Lin WC, Chang WH, Chen TJ. Risk of dementia among patients with asthma: a nationwide longitudinal study. J Am Med Dir Assoc. 2014;15:763-767. doi: 10.1016/j.jamda.2014.06.003.
  18. Peng YH, Wu BR, Su CH, Liao WC, Muo CH, Hsia TC, Kao CH. Adult asthma increases dementia risk: a nationwide cohort study. J Epidemiol Community Health. 2014;69:123-128. doi: 10.1136/jech-2014-204445.
  19. Sarınç Ulaşlı S, Oruç S, Günay E, Aktaş O, Akar O, Koyuncu T, Ünlü M. Effects of COPD on cognitive functions: a case control study. http://www.ncbi.nlm.nih.gov/pubmed/24298960 2013;61(3): 193-199.
  20. Allen S, Yeung P, Janczewski M, Siddique N. Predicting inadequate spirometry technique and the use of FEV1/FEV3 as an alternative to FEV1/FVC for patients with mild cognitive impairment. Clin Respir J. 2008;2(4):208-213. doi: 10.1111/j.1752-699x.2008.00063.x.

补充文件

附件文件
动作
1. JATS XML

版权所有 © Consilium Medicum, 2016

Creative Commons License
此作品已接受知识共享署名-非商业性使用-相同方式共享 4.0国际许可协议的许可。
 

Address of the Editorial Office:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail: e.gorbacheva@ter-arkhiv.ru

 

© 2018-2021 "Consilium Medicum" Publishing house


##common.cookie##